Evidence map›Paper›PMID 34151225›Full record

ArticleiScience2021

Dimethyl fumarate reduces hepatocyte senescence following paracetamol exposure.

Jose Meseguer-Ripolles, Baltasar Lucendo-Villarin, Carl Tucker, Sofia Ferreira-Gonzalez, Natalie Homer, Yu Wang, Philip J Starkey Lewis, Enrique M Toledo, Esther Mellado-Gomez, Joanna Simpson and 8 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Jose Meseguer-RipollesCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Baltasar Lucendo-VillarinCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Carl TuckerCentre for Inflammation Research, University of Edinburgh, 47 Little France Drive, Edinburgh EH16 4TJ, UK.
Sofia Ferreira-GonzalezCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Natalie HomerCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Drive, Edinburgh, UK.
Yu WangCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Philip J Starkey LewisCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Enrique M ToledoNovo Nordisk Research Centre Oxford (NNRCO), Novo Nordisk Ltd, Innovation Building - Old Road Campus Roosevelt Drive, OX3 7FZ Oxford, UK.
Esther Mellado-GomezNovo Nordisk Research Centre Oxford (NNRCO), Novo Nordisk Ltd, Innovation Building - Old Road Campus Roosevelt Drive, OX3 7FZ Oxford, UK.
Joanna SimpsonCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Drive, Edinburgh, UK.
Oliver FlintCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Himjyot JaiswalNovo Nordisk Research Centre Oxford (NNRCO), Novo Nordisk Ltd, Innovation Building - Old Road Campus Roosevelt Drive, OX3 7FZ Oxford, UK.
Nicola L BeerNovo Nordisk Research Centre Oxford (NNRCO), Novo Nordisk Ltd, Innovation Building - Old Road Campus Roosevelt Drive, OX3 7FZ Oxford, UK.
Allan E KarlsenNovo Nordisk Research Centre Oxford (NNRCO), Novo Nordisk Ltd, Innovation Building - Old Road Campus Roosevelt Drive, OX3 7FZ Oxford, UK.
Stuart J ForbesCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
James W DearCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Drive, Edinburgh, UK.
Jeremy HughesCentre for Inflammation Research, University of Edinburgh, 47 Little France Drive, Edinburgh EH16 4TJ, UK.
David C HayCentre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
MRC Centre for Regenerative Medicine · GBNovo Nordisk (Denmark) · DKThe Queen's Medical Research Institute · GBCentre for Inflammation Research · GB

Funding

Chief Scientist Office TCS/16/37Medical Research Council MR/K017047/1Medical Research Council MR/R015635/1
6 · The paper itself

Abstract

Liver disease is a major cause of premature death. Oxidative stress in the liver represents a key disease driver. Compounds, such as dimethyl fumarate (DMF), can activate the antioxidant response and are used clinically to treat disease. In this study, we tested the protective properties of DMF before or after paracetamol exposure. Following DMF administration, Nrf2 nuclear translocation was tracked at the single-cell level and target gene transactivation confirmed. Next, the protective properties of DMF were examined following paracetamol exposure. Transcriptomic and biochemical analysis revealed that DMF rescue was underpinned by reduced Nf-kB and TGF-β signaling and cell senescence. Following on from these studies, we employed a Zebrafish model to study paracetamol exposure

Indexed as

Cell biologyMolecular biologyToxicologyTranscriptomics

Identifiers

PMID34151225
PMCPMC8188562
OpenAlexW3163345272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.